Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Front Psychiatry ; 15: 1386842, 2024.
Article in English | MEDLINE | ID: mdl-39081533

ABSTRACT

Introduction: In the Western world, more than one-third of the patients of productive age hospitalized for severe mental illness (SMI) are parents. Each of their offspring is exposed to several stressors related to their parent's illness and hospitalization, which puts them at an increased risk of developing mental health problems. In the Czech Republic, no statistics are currently available about the families of patients with SMI, inpatients who are parents, or data about their children (ages ≤18 years). Therefore, our research aim was to describe the prevalence of parenthood among hospitalized patients with SMI, assess the number of children and determine the extent to which offspring information was present in medical records. Methods: Quantitative data from medical records (2,768 patients, aged 18-63 years, hospitalized for SMI between 2017 and 2020) from two large inpatient psychiatric facilities were examined. Parental information, demographic characteristics, number of children, and other available data were collected. Results: The prevalence of parenthood among inpatients with SMI was 34.6%. Parenthood was most prevalent among female patients and patients with recurrent depressive and bipolar disorders. The total number of offspring in 957 patient-parents was 1781 (41.7% minors under the age of 18). Information on parenthood was available in 99.7% of cases; information on the age of offspring, custody, and sociodemographic situation varies, being included in 73% to 89.7% of the medical records (some details were more frequently recorded than others). Discussion: The data obtained may help to better understand and address the specifics of these families and thus serve as a basis for the development of prevention programs.

2.
Stress ; 19(4): 383-9, 2016 07.
Article in English | MEDLINE | ID: mdl-27320489

ABSTRACT

Many modalities of cognition are affected in schizophrenia. The most common findings include dysfunctions of episodic and working memory and of executive functions. Although an inverse correlation between cortisol level and memory function has been proven, few studies have focused on the relationship between cortisol level and cognitive impairment in patients with schizophrenia. In an open, naturalistic, prospective study, consecutively hospitalized males diagnosed with first-episode schizophrenia, hypothalamic-pituitary-adrenal axis activity (afternoon cortisol levels, post-dexamethasone cortisol levels) was evaluated before and at the end of acute treatment. Psychopathology was assessed using the positive and negative syndrome scale (PANSS). Cognitive functions (memory, attention, psychomotor, verbal fluency, and executive functions) were tested after symptom alleviation using a neurocognitive test battery. In the total sample (n = 23), significant decreases in total PANSS score (including all subscales), afternoon cortisol levels, and post-dexamethasone cortisol levels occurred during the course of treatment. It was found that higher afternoon cortisol levels at the beginning of treatment were significantly related to impaired performance in memory functions. Afternoon cortisol levels were not significantly associated with other measured cognitive functions. No correlation was discovered between cognitive functions and post-dexamethasone cortisol levels. The determination of afternoon cortisol levels may serve to detect potential candidates for specific cognitive intervention immediately after the first psychotic breakthrough.


Subject(s)
Cognition Disorders/complications , Cognitive Dysfunction/complications , Hydrocortisone/blood , Schizophrenia/blood , Schizophrenic Psychology , Adolescent , Adult , Attention/physiology , Cognition/physiology , Cognition Disorders/physiopathology , Cognition Disorders/psychology , Cognitive Dysfunction/blood , Cognitive Dysfunction/physiopathology , Dexamethasone , Executive Function/physiology , Humans , Hypothalamo-Hypophyseal System/physiopathology , Male , Memory, Short-Term/physiology , Neuropsychological Tests , Pituitary-Adrenal System/physiopathology , Prospective Studies , Schizophrenia/complications , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL